-
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
-
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
-
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
-
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...
All articles
2015-10-19
Vaccine against AIDS in Phase I clinical trials
A vaccine based on HIV gp120 protein is a unique product for 15 years protection against infection. Unique, because it has been introduced by the team of Prof. Robert Gallo – a pioneer in the field of AIDS research and previous critic of disease-related vaccination.... Read more
Tags clinical trials , HIV , vaccine , AIDS , gp120
2015-08-11
Finally! We have a vaccine against malaria! Unless we don’t…
A vaccine called Mosquirix or RTS,S has been ready to use for the past couple of years. What prevents European Medicines Agency and World Health Organization from its official approval is the low efficacy.... Read more
Tags EMA , malaria , africa , WHO , vaccine , Mosquirix , RTS , S
2015-08-05
European H1N1 influenza vaccine may trigger narcolepsy
Flu pandemic in 2009 and related vaccination have left an undesirable stigma throughout Europe. More than 1300 people who received a vaccine called Pandemrix has developed narcolepsy. ... Read more
Tags flu , influenza , vaccination , vaccine , Pandemrix , narcolepsy , H1N1 , pandemic
2015-02-11